Improving the efficacy of proteasome inhibitors in the treatment of renal cell carcinoma by combination with the human immunodeficiency virus (HIV)-protease inhibitors lopinavir or nelfinavir

Publication

Improving the efficacy of proteasome inhibitors in the treatment of renal cell carcinoma by combination with the human immunodeficiency virus (HIV)-protease inhibitors lopinavir or nelfinavir

Journal Paper/Review - Jan 1, 2018

Abt Dominik, Driessen Christoph, Engeler Daniel, Schmid Hans-Peter, Slaby O, Vodinska M, Silzle T, Bader J, Kraus M, Sedlarikova L, Besse A, Besse L

Units

Urologie, Medizinische Onkologie und Hämatologie

Contact

Hans-Peter Schmid

Citation

Abt D, Driessen C, Engeler D, Schmid H, Slaby O, Vodinska M, Silzle T, Bader J, Kraus M, Sedlarikova L, Besse A, Besse L. Improving the efficacy of proteasome inhibitors in the treatment of renal cell carcinoma by combination with the human immunodeficiency virus (HIV)-protease inhibitors lopinavir or nelfinavir. BJU Int 2018; 121:600-9.

Type

Journal Paper/Review (English)

Journal

BJU Int 2018; 121

Publication Date

Jan 1, 2018

Pages

600-9